YAP and EZH2 act cooperatively to impair the tumor suppressor activity of TGFBR2 in non-small cell lung cancer [46], and the interaction between YAP and EZH2 participates in the transcriptional repression of key cell cycle regulators [45]. The gene discussed is EZH2; the disease is neoplasm.